Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATCH: Oestrogen Patches vs LHRH Agonists in Prostate Cancer
NCT00303784Phase 3Unknown
- Sponsor
- University College London
- Start
- Mar 2006
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of estradiol topical in prostate cancer (PCa), sponsored by University College London. Primary endpoint: Progression-Free Survival at 180 months. Status: unknown.
02
Drugs
estradiol topical
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00303784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303784.